老年恶性淋巴瘤患者的初始化疗剂量。 - Suppr | 超能文献

Initial chemotherapy doses for elderly patients with malignant lymphoma.

作者信息

O'Connell M J, Earle J D, Harrington D P, Johnson G J, Glick J H

出版信息

J Clin Oncol. 1986 Sep;4(9):1418.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Initial chemotherapy doses for elderly patients with malignant lymphoma.老年恶性淋巴瘤患者的初始化疗剂量。

J Clin Oncol. 1986 Sep;4(9):1418.

2

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.复发侵袭性淋巴瘤的治疗：含与不含高剂量治疗及干细胞救援的方案

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12.

3

[Malignant lymphoma--recent progress in diagnosis and treatment. (Supplement 1). Long-term survivors of malignant lymphoma patients treated with combination chemotherapy: retrospective analysis].[恶性淋巴瘤——诊断与治疗的最新进展。（增刊1）。接受联合化疗的恶性淋巴瘤患者的长期生存者：回顾性分析]

Nihon Naika Gakkai Zasshi. 1983 Oct;72(10):1342-4.

4

Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.单纯化疗作为60岁以上原发性中枢神经系统淋巴瘤患者的初始治疗：欧洲癌症研究与治疗组织脑肿瘤组的一项多中心II期研究（26952）

J Clin Oncol. 2003 Jul 15;21(14):2726-31. doi: 10.1200/JCO.2003.11.036.

5

[Combination chemotherapy in malignant lymphoma. Results of long-term follow-up].[恶性淋巴瘤的联合化疗。长期随访结果]

Rinsho Ketsueki. 1985 Jun;26(6):831-40.

6

[High dose chemotherapy with autologous stem cell transplantation].[高剂量化疗联合自体干细胞移植]

Fortschr Med. 1997 Mar 30;115(9):39-43.

7

[Cancer chemotherapy in patients of advanced age (over 75)].老年患者（75岁以上）的癌症化疗

Gan To Kagaku Ryoho. 1998 Jun;25(7):973-9.

8

Dose intensity in poor risk lymphomas: a critical factor in LNH-87 protocol?低危淋巴瘤的剂量强度：LNH - 87方案中的关键因素？

Pathol Biol (Paris). 1993 Jan;41(1):103.

9

[Cytostatic polychemotherapy in the elderly].[老年患者的细胞毒性联合化疗]

Dtsch Med Wochenschr. 1986 May 9;111(19):761-2.

10

Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma.以造血生长因子作为血液学支持的强化短程化疗及辅助放疗可改善侵袭性恶性淋巴瘤的预后。

Am J Hematol. 1996 Aug;52(4):275-80. doi: 10.1002/(SICI)1096-8652(199608)52:4<275::AID-AJH6>3.0.CO;2-P.

引用本文的文献

1

Non-Hodgkin's lymphoma in the elderly: a guide to drug treatment.老年非霍奇金淋巴瘤：药物治疗指南

Drugs Aging. 1999 Jun;14(6):447-57. doi: 10.2165/00002512-199914060-00005.

2

Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen.老年非霍奇金淋巴瘤患者的全剂量化疗：一项使用含米托蒽醌方案的可行性研究

Br J Cancer. 1990 Jul;62(1):105-8. doi: 10.1038/bjc.1990.238.

3

Cancer chemotherapy in the elderly: a series of 51 patients aged greater than 70 years.老年患者的癌症化疗：51例年龄大于70岁患者的系列研究。

Cancer Chemother Pharmacol. 1991;29(2):159-63. doi: 10.1007/BF00687328.